SEI Investments’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.83M Buy
73,515
+23,476
+47% +$611K ﹤0.01% 2014
2026
Q2
$1.56M Buy
50,039
+18,077
+57% +$447K ﹤0.01% 2076
2026
Q1
$669K Sell
31,962
-21,965
-41% -$306K ﹤0.01% 2551
2025
Q4
$478K Buy
53,927
+43,882
+437% +$378K ﹤0.01% 2523
2025
Q3
$84.4K Buy
+10,045
New +$68K ﹤0.01% 2737
2025
Q2
– Sell
-57,086
Closed -$78.2K – 2907
2025
Q1
$78.2K Buy
+57,086
New +$140K ﹤0.01% 2641
2023
Q4
– Sell
-35,020
Closed -$394K – 2677
2023
Q3
$394K Buy
+35,020
New +$214K ﹤0.01% 2204

Other funds holding TNGX

SEI Investments's TNGX Position: Q3 2026 in Review

SEI Investments increased its Tango Therapeutics (TNGX) stake by 47% in Q3 2026, buying an estimated $611K and bringing the position to 73,515 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

SEI Investments first reported a position in TNGX in Q3 2023 and has held it in 7 quarters since. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • SEI Investments held 73,515 shares of Tango Therapeutics worth $1.83M as of Q3 2026.
  • SEI Investments bought 23,476 Tango Therapeutics shares in Q3 2026, an estimated $611K.
  • Tango Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2014 holding.
  • SEI Investments first reported a position in Tango Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.